UCEDANE Trademark

Trademark Overview

On Friday, May 13, 2016, a trademark application was filed for UCEDANE with the United States Patent and Trademark Office. The USPTO has given the UCEDANE trademark a serial number of 79190047. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, August 4, 2023. This trademark is owned by LUCANE PHARMA. The UCEDANE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for the treatment of rare diseases, namely, urea cycle disorders, organic acidurias, N-acetylglutamate synthase primary deficiency
ucedane

General Information

Serial Number79190047
Word MarkUCEDANE
Filing DateFriday, May 13, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, August 4, 2023
Registration Number5126546
Registration DateTuesday, January 24, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 8, 2016

Trademark Statements

Goods and ServicesPharmaceutical products for the treatment of rare diseases, namely, urea cycle disorders, organic acidurias, N-acetylglutamate synthase primary deficiency

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, August 4, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMPerium B.V.
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressNL
Party NameLUCANE PHARMA
Party Type30 - Original Registrant
Legal Entity Type33 - NOT AVAILABLE
AddressFR
Party NameLUCANE PHARMA
Party Type20 - Owner at Publication
Legal Entity Type33 - NOT AVAILABLE
AddressFR
Party NameLUCANE PHARMA
Party Type10 - Original Applicant
Legal Entity Type33 - NOT AVAILABLE
AddressFR

Trademark Events

Event DateEvent Description
Saturday, August 20, 2016APPLICATION FILING RECEIPT MAILED
Thursday, August 11, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, August 12, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Tuesday, August 16, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 30, 2016ASSIGNED TO EXAMINER
Friday, September 2, 2016NON-FINAL ACTION WRITTEN
Saturday, September 3, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, September 7, 2016REFUSAL PROCESSED BY MPU
Wednesday, September 7, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, September 20, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 20, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 21, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 23, 2016REFUSAL PROCESSED BY IB
Monday, October 3, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 19, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 8, 2016PUBLISHED FOR OPPOSITION
Tuesday, November 8, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 17, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 24, 2017REGISTERED-PRINCIPAL REGISTER
Monday, April 24, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, April 27, 2017FINAL DISPOSITION PROCESSED
Thursday, April 27, 2017FINAL DISPOSITION NOTICE SENT TO IB
Saturday, May 13, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 4, 2023CANCELLED SECTION 71
Saturday, June 12, 2021NEW REPRESENTATIVE AT IB RECEIVED
Monday, January 24, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Saturday, July 16, 2022CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, April 4, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Monday, April 15, 2024INVALIDATION PROCESSED
Tuesday, May 7, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, August 7, 2025CHANGE OF OWNER RECEIVED FROM IB
Monday, April 15, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

Related Keywords

ucedane acidurias organic acetylglutamate synthase deficiency primary disorders cycle treatment products